共 50 条
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma
被引:16
|作者:
Benz, Matthias R.
[1
,2
,3
]
Crompton, Joseph G.
[4
]
Harder, Dorothee
[5
]
机构:
[1] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Ahmanson Translat Theranost Div, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA USA
[3] Univ Duisburg Essen, Dept Nucl Med, Essen, Germany
[4] Univ Calif Los Angeles, Div Surg Oncol, Los Angeles, CA USA
[5] Univ Hosp Basel, Clin Radiol & Nucl Med, Basel, Switzerland
关键词:
POSITRON-EMISSION-TOMOGRAPHY;
NERVE SHEATH TUMORS;
PROGNOSTIC-FACTORS;
GRADE;
METASTASES;
ANGIOSARCOMA;
GUIDELINES;
SURVIVAL;
CT;
RECURRENCE;
D O I:
10.1053/j.semnuclmed.2021.06.009
中图分类号:
R8 [特种医学];
R445 [影像诊断学];
学科分类号:
1002 ;
100207 ;
1009 ;
摘要:
Sarcomas are rare tumors of mesenchymal origin and comprise only around 1% of adult cancers. The abundance of sarcoma histiotypes, with distinct imaging characteristics, biology, clinical behavior and treatment strategy, result in a complex disease presentation, requiring management by multidisciplinary specialized sarcoma centers. Oncologic and musculoskeletal radiology guidelines provide minimal guidance and only fragmentary information on the indications of F-18-FDG PET/CT in sarcoma. Therefore, knowledge of various phenotypes with preference for bone and lymph node metastases or higher incidence of local and distant recurrence is essential to select the appropriate diagnostic imaging tests and its interpretation. Benign and malignant soft tissue and bone tumors often share common radiographic and metabolic imaging characteristics. In addition, metastases of various histiotypes might exhibit a spectrum of atypical imaging appearances. Therefore, imaging specialists need to be aware of these variants and associated pitfalls of sarcoma imaging. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:584 / 592
页数:9
相关论文